Raleigh Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Hold
48
﹤0.01% 380
2026
Q1
$10.5K Sell
48
-1,689
-97% -$413K ﹤0.01% 394
2025
Q4
$440K Buy
1,737
+1,690
+3,596% +$424K 0.16% 132
2025
Q3
$11.6K Buy
+47
New +$11.3K ﹤0.01% 358
2025
Q1
Sell
-5
Closed -$1.03K 989
2024
Q4
$1.03K Sell
5
-7
-58% -$1.54K ﹤0.01% 891
2024
Q3
$2.91K Buy
12
+7
+140% +$1.64K ﹤0.01% 776
2024
Q2
$1.1K Sell
5
-6
-55% -$1.3K ﹤0.01% 845
2024
Q1
$2.47K Buy
11
+7
+175% +$1.58K ﹤0.01% 744
2023
Q4
$880 Buy
+4
New +$846 ﹤0.01% 952
2023
Q1
Sell
-19
Closed -$3.51K 902
2022
Q4
$3.51K Sell
19
-11
-37% -$1.93K ﹤0.01% 601
2022
Q3
$5K Buy
+30
New +$6.11K ﹤0.01% 502

Other funds holding STE

Raleigh Capital Management's STE Position: Q2 2026 in Review

Raleigh Capital Management held its Steris (STE) position steady in Q2 2026 at 48 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #380.

Raleigh Capital Management first reported a position in STE in Q3 2022 and has held it in 11 quarters since. The position peaked at $440K in Q4 2025. 137 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Raleigh Capital Management held 48 shares of Steris worth $10K as of Q2 2026.
  • Raleigh Capital Management left its Steris share count unchanged in Q2 2026.
  • Steris made up ﹤0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #380 holding.
  • Raleigh Capital Management first reported a position in Steris in Q3 2022 and has held it in 11 quarters since.
  • Raleigh Capital Management's Steris position peaked at $440K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.